BASF AS

Overview

BASF AS is an active pharmaceutical ingredient (API) supplier with 6 active FDA Type II Drug Master Files, covering DOCOSAHEXAENOIC ACID ETHYL ESTER, ALGAE-SOURCED, (DHA 95 EE AS); EICOSAPENTAENOIC ACID ETHYL ESTER (EPA-E); OMEGA-3 ACID ETHYL ESTERS 78; OMEGA-3 ACID ETHYL ESTERS 90; OMEGA-3-ACID ETHYL ESTERS; OMEGA-3-ACID ETHYL ESTERS CAPSULES.

API / Drug Master Files

BASF AS holds 6 active (6 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• DOCOSAHEXAENOIC ACID ETHYL ESTER, ALGAE-SOURCED, (DHA 95 EE AS)Active2025-04-30
• OMEGA-3-ACID ETHYL ESTERS CAPSULESActive2015-06-12
• OMEGA-3-ACID ETHYL ESTERSActive2012-08-31
• EICOSAPENTAENOIC ACID ETHYL ESTER (EPA-E)Active2010-07-07
• OMEGA-3 ACID ETHYL ESTERS 78Active2010-04-21
• OMEGA-3 ACID ETHYL ESTERS 90Active2010-01-06

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to BASF AS in our records. PharmaTek screens the full directory against live FDA enforcement data.